Temporal pattern of Borrelia burgdorferi p21 expression in ticks and the mammalian host.
Open Access
- 1 March 1997
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 99 (5), 987-995
- https://doi.org/10.1172/jci119264
Abstract
The temporal synthesis of the P21 protein of Borrelia burgdorferi and the development of the humoral response to this antigen was assessed in infected mice. p21 is a member of the ospE-F gene family and its protein, P21, has been shown to be expressed by B. burgdorferi within infected mice but not by spirochetes cultured in vitro. P21 was not detected on B. burgdorferi in unfed or engorged Ixodes dammini (also known as I. scapularis) ticks, further supporting the postulate that P21 synthesis is specific for the mammalian host. In B. burgdorferi-infected mice, ospE mRNA and OspE antibodies were observed at 7 d, whereas p21 mRNA and P21-specific antibodies were detected at 21-28 d, suggesting that p21 is expressed later than ospE. Moreover, ospA mRNA was not discernible until day 14, indicating that ospA, like p21, is not expressed in the early stages of tick-transmitted murine Lyme borreliosis. Because p21 is expressed during infection in mice, we assessed the human humoral response to P21. 28% (34 of 122) of the patients with either early- or late-stage Lyme disease, and 33% (11 of 33) of the individuals with Lyme arthritis had P21 antibodies, suggesting that a P21 response may serve, at least partially, as a marker of infection. Active immunization with recombinant P21 did not protect C3H mice from tick-borne B. burgdorferi infection, and passive transfer of P21 antiserum to infected mice did not alter the course of disease. These data suggest that the antigenic structure of B. burgdorferi changes during the early stages of murine infection.This publication has 15 references indexed in Scilit:
- Characterization of a 30-kDa Borrelia burgdorferi substrate-binding protein homologueResearch in Microbiology, 1996
- Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine.The Journal of Experimental Medicine, 1996
- Direct demonstration of antigenic substitution of Borrelia burgdorferi ex vivo: exploration of the paradox of the early immune response to outer surface proteins A and C in Lyme disease.The Journal of Experimental Medicine, 1996
- Borrelia burgdorferi genes selectively expressed in the infected host.Proceedings of the National Academy of Sciences, 1995
- Induction of an outer surface protein on Borrelia burgdorferi during tick feeding.Proceedings of the National Academy of Sciences, 1995
- Early and specific antibody response to OspA in Lyme Disease.Journal of Clinical Investigation, 1994
- Serologic Diagnosis of Lyme Disease using Recombinant Outer Surface Proteins A and Band FlagellinThe Journal of Infectious Diseases, 1992
- Molecular mapping of Osp-A mediated immunity against Borrelia burgdorferi, the agent of Lyme disease.The Journal of Immunology, 1991
- Protection of Mice Against the Lyme Disease Agent by Immunizing with Recombinant OspAScience, 1990
- Megabase-sized linear DNA in the bacterium Borrelia burgdorferi, the Lyme disease agent.Proceedings of the National Academy of Sciences, 1989